Against this background, we investigated whether tenovin-6, a small-molecule compound that inhibits SIRT1 and SIRT2 functions [15], [16], exerted antitumor effects through activation of the p53 pathway in gastric cancer cells. The gene discussed is TP53; the disease is gastric cancer.